| (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis (NCT05186753) | Cogent Biosciences, Inc. | 2022-06-27 |
| Hydroxychloroquine in Isolated Cutaneous Mastocytosis Patients or Indolent Systemic Mastocytosis With Associated Skin Involvement Patients (NCT05084872) | University Hospital, Toulouse | 2021-10-01 |
| Assessment of Burden Disease in Patients With Mast Cell Disorders (NCT04615663) | University Hospital, Toulouse | 2020-01-28 |
| Mast Cell Activation Test in Allergic Disease (NCT03406325) | Hong Kong Sanatorium & Hospital | 2018-02-01 |
| Mast Cell Connect: A Registry for Patients With Mastocytosis (NCT02620254) | Blueprint Medicines Corporation | 2015-11-01 |
| The Significance of Blood-tryptase and c-Kit Mutation in Insect Venom Immunotherapy (NCT02503800) | Meir Medical Center | 2015-08-01 |
| Pregnancy and Medically Assisted Conception in Rare Diseases (NCT02450396) | Assistance Publique - Hôpitaux de Paris | 2015-06-01 |
| Treatment of Indolent Systemic Mastocytosis With PA101 (NCT02478957) | Patara Pharma | 2015-06-01 |
| Myeloproliferative Neoplasms (MPNs) Patient Registry (NCT02760238) | University Health Network, Toronto | 2015-04-01 |
| Cromoglicate in Mastocytosis (NCT01701843) | LEO Pharma | 2012-10-01 |
| A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies (NCT01384513) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2011-08-04 |
| Study on Mastocytosis for Rupatadine Treatment (NCT01481909) | Marcus Maurer | 2010-09-01 |
| Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V Mutation (NCT01266369) | AB Science | 2007-02-01 |
| Dasatinib as Therapy for Myeloproliferative Disorders (MPDs) (NCT00255346) | M.D. Anderson Cancer Center | 2005-11-15 |
| Efficacy of AB1010 in Patients With Systemic Indolent Mastocytosis (NCT00831974) | AB Science | 2004-10-01 |
| Molecular Mechanisms and Diagnosis of Mastocytosis (NCT00336076) | University of Michigan | 2004-07-01 |
| Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing (NCT00047918) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-10-01 |
| Study of Factors Regulating Mast Cell Proliferation (NCT00044122) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-09-18 |
| Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate (NCT00038675) | M.D. Anderson Cancer Center | 2001-06-01 |
| Stem Cell Transplantation to Treat Systemic Mastocytosis (NCT00006413) | National Heart, Lung, and Blood Institute (NHLBI) | 2000-10-13 |
| Study of Mast Cell Precursors (NCT00001756) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-12-03 |
| Evaluation and Long-Term Follow-Up of Patients With Allergic and Inflammatory Disorders (NCT00557895) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-08-26 |
| Characteristics of Mast Cells in Mastocytosis (NCT00001356) | National Institute of Allergy and Infectious Diseases (NIAID) | 1993-05-01 |